Stefan Gingele

9PUBLICATIONS
64CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)AutoimmunityPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 12, 2026
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany - expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN).

|Mar 26, 2026
Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysis.

Patricia Kirschner, Franz F Konen, Franziska Axhausen

|Mar 09, 2026
Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple Sclerosis.

Gudrun M Körner, Thiemo M Möllenkamp, Konstantin F Jendretzky

|Jan 20, 2026
Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.

Franz Felix Konen, Franziska Axhausen, Stephanie Wolff

|Nov 19, 2025
Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.

Stefan Gingele, Anna Christina Saparilla Pietschmann, Konstantin F Jendretzky

|Oct 07, 2025
Polyneuropathy in hereditary and wildtype transthyretin amyloidosis, comparison of key clinical features and red flags.

Janna M Siemer, Lea Grote-Levi, Anja Hänselmann

Pageof 2

Frequent Collaborators

4 joint publications

Thomas Skripuletz

3 joint publications

Franz Felix Konen

2 joint publications

Tania Kümpfel

2 joint publications

Joachim Havla